Cargando…
Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
Considerable evidence links urokinase plasminogen activator (uPA) bound to its surface receptor (uPAR) with enhanced invasiveness of cancer cells. By blocking uPAR expression in human epidermoid carcinoma cells (HEp3), we have now identified an additional and novel in vivo function for this receptor...
Autores principales: | Yu, W., Kim, J., Ossowski, L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139877/ https://www.ncbi.nlm.nih.gov/pubmed/9151680 |
Ejemplares similares
-
Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling
por: Ghiso, Julio A. Aguirre, et al.
Publicado: (1999) -
Protracted dormancy of pre-leukemic stem cells
por: Ford, A M, et al.
Publicado: (2015) -
Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis
por: Shmakova, Anna A., et al.
Publicado: (2022) -
The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016) -
Malignant hypertension with protracted but not definitive oligoanuric acute kidney failure
por: Yadla, Manjusha, et al.
Publicado: (2013)